The model of lineage plasticity described in SCLC, with SCLC-A transforming to SCLC-N mediated by MYC activation (Ireland et al., 2020), has similarities to the transformation of prostate cancer (Li et al., 2021a) and pancreatic cancer (Farrell et al., 2017). This evidence concerns the gene MYC and prostate cancer.